An interventional study of Viable Cartilage Allograft Implantation and Arthroscopic Drilling and Chondroplasty in Osteochondritis Dissecans of Ankle and Joints of Foot, sponsored by Children's Hospital of Eastern Ontario. Not yet recruiting. Open to participants aged 5 Years to 18 Years. Per ClinicalTrials.gov, last updated 2026-11-18.
Sponsored by Children's Hospital of Eastern Ontario · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Osteochondritis dissecans (OCD) of the talus is a condition affecting the bone and cartilage of the ankle joint. It can cause pain, swelling, stiffness, and difficulty participating in sports and daily activities. Children and adolescents with persistent symptoms or unstable lesions may require surgery when nonsurgical treatments are unsuccessful.
Two surgical approaches used to treat this condition are arthroscopic drilling and chondroplasty, which aim to stimulate healing of the affected bone and cartilage, and viable cartilage allograft implantation, which uses donated cartilage material to repair the damaged area. There is limited evidence comparing these treatments in children and adolescents, and it is not known whether one approach provides better outcomes.
This pilot randomized controlled trial aims to assess the feasibility of conducting a larger study comparing these two surgical treatments in pediatric patients with talar OCD. Approximately 20 participants requiring surgery will be recruited at the Children's Hospital of Eastern Ontario (CHEO) and randomly assigned to receive either viable cartilage allograft implantation (CartiMax®) or arthroscopic drilling and chondroplasty.
The primary objective is to assess the feasibility of recruitment, acceptance of randomization, participant retention, completion of imaging and questionnaires, and adherence to the study procedures. Secondary objectives include exploring differences in ankle pain, function, healing on magnetic resonance imaging (MRI), complications, and the need for additional surgery.
Participants will undergo postoperative rehabilitation according to standard clinical care and will be followed for up to 24 months after surgery.
The findings will help determine whether a larger multicentre randomized trial is feasible and provide preliminary information about healing and recovery following each surgical treatment. This pilot study is not designed to determine which treatment is more effective.
Osteochondritis dissecans (OCD) of the talus is a condition that affects the bone and cartilage in the ankle joint. It can cause pain, swelling, stiffness, and difficulty participating in sports and everyday activities. Some children and adolescents with this condition require surgery when treatments such as rest, activity restrictions, and immobilization have not improved their symptoms.
Two surgical approaches are available to treat this condition. One involves drilling small holes into the affected bone and smoothing damaged cartilage to encourage healing. The other involves placing donated cartilage material into the damaged area to support cartilage repair. It is not yet known whether one approach leads to better healing and recovery in children and adolescents.
The main purpose of this pilot study is to determine whether it is feasible to conduct a larger study comparing these two surgical treatments. Researchers will assess whether enough patients can be recruited, whether families are willing to accept random assignment to either treatment, and whether participants can complete the required follow-up visits, imaging, and questionnaires.
The study will include approximately 20 children and adolescents who require surgery for osteochondritis dissecans of the talus at the Children's Hospital of Eastern Ontario (CHEO) in Ottawa, Canada. Participants will be randomly assigned, like flipping a coin, to receive one of two surgical treatments:
All participants will receive the same standard postoperative rehabilitation approach. Follow-up assessments will take place approximately 2 weeks, 6 weeks, 3 months, 6 months, 12 months, and 24 months after surgery. Researchers will assess ankle pain, function, healing on imaging, return to sports, complications, and whether additional surgery is needed.
The researchers expect this pilot study to help determine whether a larger randomized trial can be successfully conducted. The study will also provide early information about healing and recovery after each treatment. Because this is a small pilot study, it is not designed to determine which surgical treatment is better.
31 studies on the registry are indexed under Osteochondritis Dissecans; 9 are open to participants now.
This study's planned enrollment of 20 is below the median of 43 across 18 interventional studies indexed under Osteochondritis Dissecans.
Browse Osteochondritis Dissecans studies →Children's Hospital of Eastern Ontario is the lead sponsor of 85 studies on the registry; 11 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Participants undergo arthroscopic lesion preparation followed by implantation of CartiMax viable cartilage allograft into the damaged area of the talus. Standard postoperative rehabilitation is provided.
Procedure: Viable Cartilage Allograft Implantation
Participants undergo arthroscopic drilling and chondroplasty to remove or smooth unstable cartilage and stimulate healing of the underlying bone. Standard postoperative rehabilitation is provided.
Procedure: Arthroscopic Drilling and Chondroplasty
Participants undergo arthroscopic preparation of the talar osteochondral lesion followed by implantation of CartiMax viable cartilage allograft, consisting of viable cartilage fibers and cartilage allograft matrix. The graft is placed into the cartilage defect to support repair. Participants follow the standard postoperative rehabilitation protocol.
Participants undergo arthroscopic drilling and chondroplasty of the talar osteochondral lesion. Unstable cartilage is removed or smoothed, and small channels are drilled into the affected bone to stimulate healing. Participants follow the standard postoperative rehabilitation protocol.
Recruitment Rate
Number of participants enrolled per year during the recruitment period. Recruitment feasibility will be assessed against a target of at least 10 participants enrolled per year.
Time frame: 24 months
Questionnaire Completion Rate at 6 Months
Proportion of randomized participants who complete the required 6-month postoperative pain and ankle function assessments, including the Visual Analogue Scale (VAS) and American Orthopaedic Foot and Ankle Society (AOFAS) ankle-hindfoot score. The target questionnaire completion rate is at least 80%.
Time frame: 6 months after surgery
MRI Completion Rate at 6 Months
Proportion of randomized participants who complete the scheduled 6-month postoperative magnetic resonance imaging (MRI) assessment. The target MRI completion rate is at least 80%.
Time frame: 6 months after surgery
Participant Retention Rate at 6 Months
Proportion of randomized participants who remain in the study and complete the 6-month postoperative follow-up assessment. The target retention rate is at least 70%.
Time frame: 24 months
Randomization Acceptance Rate
Proportion of eligible patients approached for participation who consent to random assignment to either surgical treatment. The target randomization acceptance rate is at least 80%.
Time frame: 24 months
Adherence to Randomized Treatment Allocation
Proportion of randomized participants who undergo their assigned surgical intervention, either viable cartilage allograft implantation or arthroscopic drilling and chondroplasty. Crossovers and deviations from assigned treatment will be documented.
Time frame: At the time of surgery (assessed up to 1 hour)
No study locations are listed for this record.
Plan to share: No
Start is estimated for Jan 2027; primary completion for Jan 2029, 24 months later.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Children's Hospital of Eastern Ontario